Review for "Hypercalcemia at diagnosis of diffuse large B‐cell lymphoma is not uncommon and is associated with high‐risk features and a short diagnosis‐to‐treatment interval"

2020 ◽  
Author(s):  
Eric Van Den Neste
Keyword(s):  
High Risk ◽  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Large B Cell Lymphoma ◽  
Treatment Interval ◽  
Large B Cell

Hypercalcemia at diagnosis of diffuse large B‐cell lymphoma is not uncommon and is associated with high‐risk features and a short diagnosis‐to‐treatment interval

2020 ◽  
Vol 38 (3) ◽  
pp. 326-333
Author(s):  
Anne‐Cécile Gauchy ◽  
Lukshe Kanagaratnam ◽  
Anne Quinquenel ◽  
Baptiste Gaillard ◽  
Cyrielle Rodier ◽  
...  
Keyword(s):  
High Risk ◽  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Large B Cell Lymphoma ◽  
Treatment Interval ◽  
Large B Cell

scholarly journals Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial

2020 ◽  
Vol 31 (9) ◽  
pp. 1251-1259 ◽  
Author(s):  
A.K. McMillan ◽  
E.H. Phillips ◽  
A.A. Kirkwood ◽  
S. Barrans ◽  
C. Burton ◽  
...  
Keyword(s):  
High Risk ◽  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Phase 2 ◽  
Front Line ◽  
Large B Cell Lymphoma ◽  
Large B Cell
Sign in / Sign up

Export Citation Format

Share Document